Purchase Order 36C24823P0333
Award Date
11/30/22
Potential Completion Date
12/2/22
Potential Value
$288K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Cardinal Health, Inc.
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for YESCARTA Drug. The contract has a period of performance from March 22, 2022 through March 28, 2022 and utilizes a firm fixed price pricing structure. Cardinal Health, Inc. will provide YESCARTA, a chimeric antigen receptor T-cell therapy, as the prime contractor.</p>
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for emergency order of Yescxart drugs in the quantity of one. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, Inc., will provide the drugs from its Dublin, Ohio facility between April 20, 2022 and April 26, 2022 under firm fixed pricing terms. No applicable...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $284,904.52 purchase order contract to Cardinal Health, Inc., doing business as Cardinal Health, for YESCART (AXICABTAGENE CILOLEUCEL INJ SUSP). The place of performance is Dublin, OH and the contract period is from November 30, 2021 to December 1, 2021. The pricing structure is firm fixed price. No subcontractors were identified.</p>
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA-VHA) awarded a $287,923.29 purchase order contract to Cardinal Health, Inc. for YESCARTA Therapy. As the prime contractor, Cardinal Health Inc. Division - doing business as Cardinal Health, will provide YESCARTA Therapy from August 18, 2022 through February 28, 2023 in Dublin, Ohio under firm fixed pricing terms. YESCARTA is a chimeric antigen receptor (CAR) T-cell immunotherapy...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $307,114.91 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for emergency TECARTUS infusion services. Cardinal Health, Inc. will provide these services as the prime contractor from April 25, 2023 through May 3, 2023 in Dublin, Ohio under a firm fixed price contract structure. No subcontractors were identified.</p>
Cardinal Health, Inc. was awarded a $285,000 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to deliver YESCARTA (axicabtagene ciloleucel) injections for cancer treatment. As the prime contractor, Cardinal Health will provide the chimeric antigen receptor T-cell immunotherapy drug manufactured by Kite Pharma, Inc. from its manufacturing facility in Dublin, Ohio for administration to veterans through VA medical centers...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $153,947.27 firm fixed price delivery order to Cardinal Health 414, LLC for radiopharmaceutical products and services. As the prime contractor, Cardinal Health 414 is a division of Cardinal Health, Inc., a major medical products and services provider. This order was awarded on December 1, 2020 with a completion date of November 30, 2021 to support the VA's healthcare programs in...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health, Inc. for the delivery of one treatment of the cancer drug YESCARTA. The contract has a firm fixed price of $284,904.52 and a completion date of May 28, 2021. As the prime contractor, Cardinal Health will leverage its expertise in nuclear pharmacy services and distribution capabilities to ensure reliable delivery of this essential radiopharmaceutical product to the VA...
This is a federal contract award from the Defense agency Medical Supply Chain to Cardinal Health, Inc., a global healthcare services and products company, for pharmaceutical and medical supplies. The contract has a ceiling value of $1,125.40 and is a delivery order contract with a firm fixed price pricing type. The award is not set aside for any specific business type, indicating Cardinal Health's ability to compete on an unrestricted basis. The contract has an ultimate completion date of...
The Department of Veterans Affairs (VA) awarded a $80,260.00 firm fixed-price purchase order contract to Cardinal Health, Inc. for emergency medical supplies. The contract has no set-aside designation and is part of the VA's larger single-award indefinite delivery contract valued at $773,677.24 for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. Cardinal Health's subsidiary, The Harvard Drug Group, L.L.C., also holds a separate...